Biotech failure, 2002 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech failure, 2002

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (68)	5/20/2002 1:37:16 AM
From: Miljenko Zuanic	Read Replies (1) of 130

<< Remember, virtually everyone was going "huh?" when Bristol Knows Squibb signed the deal.>> Not all, but this deal for sure will be remembered for some times. Feuerstein is just following main stream: What is going down will go down further! It was WS and brokerage hype who give him meat to write stories. Regards the ABGX, OSIP, DNA, and others who are making progress and trying hard to bring new cancer drugs need first to report their data, before investors decide where are their place. Even, I do not think that IMCL will take hard beating tomorrow. Yes, short and weak hand will act first than think. However, this is not the end for C225. It will take longer to reach market, and give competitive drugs chance to close gap. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next